Updates from The Motley Fool

Latest updates on Seattle Genetics from Fool.com.


Stock Performance

SGEN vs. S&P 500 | 2 Year Performance
SGEN 1-Day Stock Chart
SGEN 5-Day Stock Chart
SGEN 1-Month Stock Chart
SGEN 3-Month Stock Chart
SGEN 6-Month Stock Chart
SGEN 1-Year Stock Chart
SGEN 2-Year Stock Chart
SGEN 5-Year Stock Chart
View Interactive SGEN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Seattle Genetics.
Current Price: $35.48
Prev Close: $37.29
Open: $35.75
Bid: $34.83
Ask: $39.80
Day's Range: $35.17 - $37.49
52wk Range: $26.02 - $52.33
Volume: 1,671,861
Avg Vol 991,241
Market Cap: $4.95B
P/E (ttm): -40.10
EPS (ttm): -$0.93
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Seattle Genetics.
CAPS Rating 4 out of 5
 
468 Outperform
33 Underperform
CAPS All Stars
 
81 Outperform
12 Underperform

How do you think Seattle Genetics will perform against the market?



You pick for Seattle Genetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Clay B. Siegall, CEO

78% Approve

Based on 17 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Seattle Genetics.

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers